Med Fam Apolo S.R.L.
- Address
- lock Available on a paid plan
Bacterial Infections and Mycoses Research
At Med Fam Apolo S.R.L. in Călărași, clinical research in this area focuses on meningococcal infection and other bacterial infections. The studies are centered on evaluating whether a new meningococcal ACYW conjugate vaccine can generate an immune response comparable to an established vaccine, with attention to both protection and safety in young children.
- Testing the immune response to a meningococcal vaccine in infants and toddlers
- Comparing vaccine performance to help confirm non-inferiority in antibody response
- Assessing safety alongside protection against meningococcal serogroups A, C, W, and Y
This work supports better prevention of serious meningococcal disease and helps clarify how well newer vaccination options perform in early childhood.
Virus Diseases Research
Clinical trials at this site also address virus diseases, especially varicella and measles, mumps, and rubella. The research is designed to evaluate immune response and safety when vaccines are given in different ways, with the goal of improving protection for healthy children.
- Studying an investigational chickenpox vaccine for its ability to trigger a strong immune response
- Evaluating a marketed MMR vaccine for effectiveness when administered by a different route
- Comparing seroresponse and antibody levels to understand vaccine performance
These trials focus on making vaccination more effective and practical, while supporting stronger protection against common childhood viral infections.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1GlaxoSmithKline Biologicals1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 442 other sites in Romania
Therapeutic Area Benchmark — Romania
Select a therapeutic area to compare against other sites in Romania.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Romania
Market Share
Country: Romania
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Med Fam Apolo S.R.L.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Immunogenicity and Safety of Intramuscular GSKVX000000025896 and Priorix Versus Subcutaneous Varicella Virus Oka/Merck Strain in Healthy Children Aged 12-15 Months | GlaxoSmithKline Biologicals | Phase III | Recruiting | Dec 2025 | — |
IMP list
lock Showing 1 of 10 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| GSKVX000000025896 | 1 | Unknown | 2025-12-10 | 2025-12-10 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.